Journal Title
CANCER RESEARCH

CANCER RES

ISSN / eISSN
0008-5472 / 1538-7445
Aims and Scope
Cancer Research is the most frequently cited cancer journal in the world. The journal publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention and epidemiological research. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. The main scope of the Journal is captured in its primary subsections, which focus on molecular and cellular pathobiology, tumor and stem cell biology, therapeutics and targets, microenvironment and immunology, prevention and epidemiology, and integrated systems and technology.
Subject Area

ONCOLOGY

CiteScore
16.90 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - Oncology Q1 #25/366
Medicine - Cancer Research Q1 #19/214
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
ONCOLOGY - SCIE Q1
H-index
411
Country/Area of Publication
UNITED STATES
Publisher
American Association for Cancer Research Inc.
Publication Frequency
Semimonthly
Year Publication Started
1941
Annual Article Volume
345
Open Access
NO
Contact
AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
Hello, I would like to ask when and how you plan to appeal? Did you conduct an experiment to address the reviewer's comments and then use the experimental results for the appeal? How long did it take between receiving the rejection message and filing the appeal? Thank you!
2021-06-19

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation